- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05090241
Frailty Prevention in Elders From Reunion Island (5P-ECHELLE)
Frailty Prevention in Elders From Reunion Island: Detection of Frailty, Age-related Issues and Risk of Falling Among Community Dwelling Elderly
In Reunion Island, people encounter environmental and social conditions leading to premature ageing and subsequent frailty.
The study evaluates tools, supported by the latest scientific advances in "machine learning" to detect, identify and measure frailty in order to give health professionals the means to act early through preventive actions.
Study Overview
Status
Intervention / Treatment
Detailed Description
The 5P research program is a 6-years program that started in 2016.
Its objective is to set up tools, supported by the latest scientific advances in "machine learning" to detect, identify and measure frailty in order to give health professionals the means to act early through preventive actions.
The diversity and transversal nature of the research disciplines in this program make it original. This allows it, through common protocols, to explore the concept of frailty and the care pathway of the elderly through different prisms of complementary observations.
This program is deployed in three stages: proof of principle, proof of concept (called 5P-PILOT) and "the Scaling up" (called 5P-ECHELLE). It combines an evaluation of the acceptability of technological detection tools, a measurement of the impact of prevention workshops on the loss of autonomy among independent frail elderly people and an evaluation of tools to help detect frailty.
The ageing of the population poses a real societal challenge. The loss of autonomy, which is the result of multiple individual or environmental factors for the ageing person, has a costly impact in terms of recourse to care and on the people around them. It is therefore urgent to act on the levers of frailty by acting as early as possible to prevent its irreversibility.
The "5P ECHELLE" project aims to develop a semi-automatic and non-medical method for detecting weak signals of frailty in older people, by combining standardized clinical indicators for assessing their state of robustness with large-scale intelligent detection devices that allow for longitudinal monitoring, while integrating the necessary participatory dimension of the subject.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Saint-Joseph, Réunion, 97480
- Cabinet Dr HUCHOT et Dr GENSOUS
-
-
La Réunion
-
Saint-Philippe, La Réunion, Réunion, 97417
- MSPU Care Austral
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Persons over 65 years of age
- Retired persons
- Person affiliated to or benefiting from a social security scheme.
- Free and informed consent given
Exclusion Criteria:
- Persons referred to in Articles L1121-5 to L1121-8 of the French Public Health Code (corresponding to all protected persons), pregnant women, parturients, nursing mothers, persons deprived of their liberty by judicial or administrative decision, persons subject to a legal protection measure
- Difficulty in understanding the French language
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the number of falls
Time Frame: Change from baseline in the number of falls to 6 months.
|
Collection of falls by diary with monthly telephone survey for 6 months.
A fall is defined as an event in which an individual inadvertently falls to the ground or any other surface below the level of origin.
|
Change from baseline in the number of falls to 6 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in balance performance
Time Frame: Change from baseline in balance performance to 6 months.
|
The balance measurement was performed on a force platform.
The senior citizen was positioned barefoot on the strength platform.
The measurement was performed for 30 seconds with eyes open, then with eyes closed for 30 seconds.
Postural control acquisition data, and more specifically the displacement of the center of pressure was measured in both the medio-lateral and antero-posterior dimensions.
Small variations are better.
|
Change from baseline in balance performance to 6 months.
|
|
Change in gait performance
Time Frame: Change from baseline in balance and gait performance to 6 months.
|
The gait test was carried out using sensors to analyze and retrieve data from the participant's walk (gait speed, step length, duration of the double support phase).
Four X-sens® Motion Tracker Wireless sensors were positioned on the clothes with headbands as follows: one at forehead level on the median sagittal line, the second opposite the L4 vertebra and the last two on the dorsal surface of the right and left feet at mid-foot level.
Then, the patient walked 10 meters in a straight line, made a half turn and walked 10 meters again.
Higher gait speed is better.
|
Change from baseline in balance and gait performance to 6 months.
|
|
Frailty according to "Fried et al" criteria
Time Frame: Assessed at baseline
|
The Fried criteria are a list of 5 criteria to define the elderly frailty. Weight loss: "In the last year, have you lost more than 3 kilograms unintentionally?" If yes, then frail for weight loss criterion. Exhaustion: the following two statements are read. (a) I felt that everything I did was an effort; (b) I could not get going. The question is asked "How often in the last week did you feel this way?" 0 = rarely or none of the time (< 1 day), 1 = some or a little of the time (1-2 days), 2 = a moderate amount of the time (3-4 days), or 3 = most of the time. Subjects answering "2" or "3" to either of these questions are categorized as frail by the exhaustion criterion. Walk Time: Cutoff for time to walk 4 meters criterion for frailty, >= 7 seconds Grip Strength: cutoff for grip strength (Kilogram) criterion for frailty < 30 for men, <17 for women. A person is frail if 3 out of 5 criteria are found, pre-frail if 1 or 2 are found, or robust if no criterion are found. |
Assessed at baseline
|
|
The Short Physical Performance Battery (SPPB)
Time Frame: Assessed at baseline
|
The Short Physical Performance Battery is the sum of the scores on three criteria: the balance test, the walking speed test and the chair lift test.
This test is used to evaluate the physical performance of an individual.
Total points 0 - 12. Higher scores mean a better outcome.
|
Assessed at baseline
|
|
Falls Risk for Older People in the Community (FROP-COM)
Time Frame: Assessed at baseline
|
The FROP-COM consists of 13 risk factors being rated, most on a graded 0-3 scale.
Higher scores mean a worse outcome.
|
Assessed at baseline
|
|
Who's Integrated care for older people (ICOPE) screening tool
Time Frame: Assessed at baseline
|
Who's "ICOPE" screening tool consists of 5 tests: Cognitive decline: Remember three words: flower, door, rice (for example) and recalls, Limited mobility: Chair rise test: Rise from chair five times without using arms. Did the person complete five chair rises within 14 seconds? Weight loss: Have you unintentionally lost more than 3 kg over the last three months? Visual impairment: Do you have any problems with your eyes: difficulties in seeing far, reading, eye diseases or currently under medical treatment (e.g. diabetes, high blood pressure)? Hearing lost: Hears whispers (whisper test). Depressive symptoms: Over the past two weeks, have you been bothered by
|
Assessed at baseline
|
|
The "Codex" score
Time Frame: Assessed at baseline
|
The "Codex" test assesses the cognitive functions of elderly subjects in less than 3 minutes. It test involves memory, executive functions, attention, and visual-spatial praxis. It includes:
If the 2 tasks (Clock and 3 words recall) are normal, the test is over: CODEX normal. If the 2 tasks are abnormal, the test is finished : CODEX abnormal! |
Assessed at baseline
|
|
Height in meters
Time Frame: Assessed at baseline
|
Height in meters using a height gauge.
Weight and height will be combined to report Body Mass Index (BMI) in kg/m^2
|
Assessed at baseline
|
|
Weight in kilograms
Time Frame: Assessed at baseline
|
The weight in kilos using a scale.
Weight and height will be combined to report Body Mass Index (BMI) in kg/m^2.
|
Assessed at baseline
|
|
The Evaluation of precariousness and health inequalities in the examination centers" (EPICES) score
Time Frame: Assessed at baseline
|
EPICES score (Evaluation of precariousness and health inequalities in the examination centers) is an individual indicator of precariousness that takes into account the multidimensional nature of precariousness.
multidimensional nature of precariousness.
The main interest of the EPICES score is to apprehend populations which, while not covered by traditional administrative indicators of precariousness, present the same health risks.
The answer to each question is The sum of the 11 answers gives the EPICES score.
The score is The score is continuous and varies from 0 (no precariousness) to 100 (maximum precariousness).
The threshold of 30 is considered the precariousness threshold according to "EPICES".
|
Assessed at baseline
|
|
Standardised Assessment of Personality - Abbreviated Scale (SAPAS) Moran
Time Frame: Assessed at baseline
|
A simple 8-question personality disorder screening test.
A total score of 3/8 or more indicates personality disorder is likely.
|
Assessed at baseline
|
|
The frailty of groups with equal resources (FRAGIRE) grid.
Time Frame: Assessed at baseline
|
The FRAGIRE grid is an assessment tool that aims to detect, among non-dependent retirees.
It consists of 17 multiple-choice questions on physiological feelings, state of health, depression, pleasure, suicidal thoughts, social and cultural environment, taste, appetite, oral health, motor skills and 1 question for the evaluator on the person's state of health.
Higher scores mean a worse outcome.
|
Assessed at baseline
|
|
Medical Outcomes Study 36-item Short-Form (SF-36)
Time Frame: Assessed at baseline
|
Quality of life assessed by Short-Form 36 questionnaire.
Higher scores mean a better outcome.
|
Assessed at baseline
|
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: Assessed at baseline
|
The Hospital Anxiety and Depression Scale scale is an instrument for screening for anxiety and depressive disorders.
It includes 14 items rated from 0 to 3. Seven questions relate to anxiety (total A) and seven others to the depressive dimension (total D), thus making it possible to obtain two scores (maximum score for each score = 21).
Higher scores mean a worse outcome.
|
Assessed at baseline
|
|
Hearing Handicap Inventory for the Elderly Screening (HHIE-S)
Time Frame: Assessed at baseline
|
The Hearing Handicap Inventory for the Elderly Screening is a self-assessment tool containing 10 questions aimed to assess the impact of hearing loss in the emotional and social-situational adjustments of elderly patients who are not institutionalized.
Higher scores mean a worse outcome.
|
Assessed at baseline
|
|
Mini Mental State Examination (MMSE)
Time Frame: Assessed at baseline
|
The Mini-Mental State Examination is a cognitive assessment instrument developed for rapid screening of cognitive deficits in 30 questions.
Higher scores mean a better outcome.
|
Assessed at baseline
|
|
World Health Organization (WHO) visual acuity measurement
Time Frame: Assessed at baseline
|
Measurement of visual acuity using the Raskin E scale.
Distance visual acuity measured at 3 meters and near visual acuity at 40 centimeters.
Score expressed in 1/(arc min).
Higher scores mean a better outcome.
|
Assessed at baseline
|
|
The Mini Nutritional Assessment (MNA)
Time Frame: Assessed at baseline
|
The MNA consists of two parts with 18 items and a score out of 30.
The sum of the MNA score distinguishes between elderly patients with: 1) adequate nutritional status, MNA ≥ 24; 2) protein-calorie malnutrition, MNA < 17; 3) at risk of malnutrition, MNA between 17 and 23.5.
Higher scores mean a better outcome.
|
Assessed at baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Jean-Marc EYCHENE, MD, Centre Hospitalier Universitaire de la Réunion
- Study Director: Pierre-Paul VIDAL, MD, Laboratoire Borelli
- Study Director: Frederic SANDRON, Institut de Recherche pour le Développement (IRD)
- Study Director: Jean-Marc FRANCO, MD, Universite de La Reunion
Publications and helpful links
General Publications
- Legrand F, Eychene JM, Audiffren J, Klein A, Labourdette C, Nicolai A, Sandron F, Vidal PP. The 5P program, personalized and participatory primary prevention pathway: Rational and design of a clinical trial in general practice. Contemp Clin Trials Commun. 2021 Jun 3;22:100786. doi: 10.1016/j.conctc.2021.100786. eCollection 2021 Jun.
- Legrand F, Eychene JM, Audiffren J, Klein A, Labourdette C, Nicolai A, Sandron F, Vidal PP. Description of Participants in the "Atout Age Mobility" Prevention Workshops at the University Hospital Center of La Reunion: A Prospective Study. J Nutr Health Aging. 2021;25(5):628-636. doi: 10.1007/s12603-021-1604-8.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202005974
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Frail Elderly Syndrome
-
Sultan Abdulhamid Han Training and Research Hospital...Not yet recruitingFrail Elderly Syndrome
-
DSM Nutritional Products, Inc.CompletedFrail Elderly | Pre-frail ElderlyNetherlands
-
University of SalernoAzienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'AragonaNot yet recruitingHeart Failure | Frail Elderly Syndrome | Prefrail Elderly
-
McMaster UniversityAlberta Health services; Saskatchewan Health Authority - Regina Area; Canadian... and other collaboratorsActive, not recruitingFrail Elderly SyndromeCanada
-
Università degli Studi del Piemonte Orientale "Amedeo...Completed
-
University of Massachusetts, WorcesterAnesthesia Patient Safety FoundationCompleted
-
School of Health Sciences GenevaInstitution genevoise de maintien à domicileCompletedFrail Elderly Syndrome
-
University of GlasgowNHS Greater Glasgow and ClydeUnknownFrail Elderly SyndromeUnited Kingdom
-
Federico II UniversityRecruiting
Clinical Trials on Instrumental measurement of balance and gait
-
Lithuanian University of Health SciencesRecruiting
-
University GhentCompletedDementia | Gait | Muscle Tone | Balance | Paratonia | Fine Motor FunctionBelgium
-
Forschungszentrum JuelichHeinrich-Heine University, DuesseldorfRecruitingParkinson Disease | AtaxiaGermany
-
Princess Nourah Bint Abdulrahman UniversityActive, not recruitingChildren With Acquired Brain InjurySaudi Arabia
-
Centre Hospitalier Universitaire DijonRecruitingBone Reconstruction by Free Fibula FlapFrance
-
Ankara Yildirim Beyazıt UniversityCompleted
-
Foot Surgery Center of Northern ColoradoAssociation of Extremity Nerve SurgeonsRecruitingDiabetic Peripheral NeuropathyUnited States
-
Istanbul University - Cerrahpasa (IUC)Not yet recruiting
-
Kocaeli Sağlık ve Teknoloji ÜniversitesiCompletedPostmenopausal Women | Functional Performance | Knee Osteoarthristis | Muscle Strenght | Isokinetic TestTurkey (Türkiye)
-
GULIN FINDIKOGLUCompletedDiabetes Mellitus, Type 2 | Gait Disorder, SensorimotorTurkey